Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes.

Luba Metlitskaia1, Jennifer E Cabralda, Dinar Suleman

  • 1Micrologix Biotech Inc., 3650 Wesbrook Mall, Vancouver, BC, Canada.

Biotechnology and Applied Biochemistry
|May 25, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European foulbrood disease and protein supplementation in honey bee (<i>Apis mellifera</i> L.) colonies pollinating highbush blueberries in British Columbia.

PeerJ·2026
Same author

A non-invasive method for profiling the gut microbiome and virome of honey bee queens.

Scientific reports·2026
Same author

Neonicotinoid-induced signature dysbiosis identified via metagenomic sequencing of the honey bee gut microbiome.

Scientific reports·2025
Same author

Insights from U.S. beekeeper triage surveys following unusually high honey bee colony losses 2024-2025.

The Science of the total environment·2025
Same author

Omics Insights Into the Effects of Highbush Blueberry and Cranberry Crop Agroecosystems on Honey Bee Health and Physiology.

Proteomics·2025
Same author

Regional patterns and climatic predictors of viruses in honey bee (Apis mellifera) colonies over time.

Scientific reports·2025

Developing cost-effective recombinant production of antimicrobial peptides is crucial for therapeutic applications. This study presents a method using Escherichia coli to produce large quantities of these vital defense molecules efficiently.

Area of Science:

  • Biochemistry
  • Microbiology
  • Biotechnology

Background:

  • Antimicrobial peptides (AMPs) are essential natural defense molecules in animals and plants.
  • These peptides exhibit potent activity against drug-resistant pathogens but face production challenges for therapeutic use.
  • Current chemical synthesis methods are often costly for large-scale AMP production.

Purpose of the Study:

  • To develop a cost-effective and scalable method for producing antimicrobial peptides.
  • To overcome the limitations of chemical synthesis for therapeutic peptide manufacturing.
  • To optimize recombinant production of cationic antimicrobial peptides.

Main Methods:

  • Recombinant production of multiple copies of antimicrobial peptides as fusion proteins in Escherichia coli.

Related Experiment Videos

  • Accumulation of fusion proteins in bacterial inclusion bodies, constituting over 50% of total cellular protein.
  • Release of active antimicrobial peptides using chemical reagents and purification via chromatography.

    • Main Results:

    • Demonstrated a method for high-yield recombinant production of antimicrobial peptides.
    • Achieved accumulation of fusion proteins as a significant portion of cellular protein content.
    • Successfully released and purified active antimicrobial peptides from inclusion bodies.

    Conclusions:

    • Developed a cost-effective recombinant strategy for manufacturing antimicrobial peptides.
    • The method addresses industrial-scale production challenges for therapeutic peptide manufacturing.
    • This approach offers a viable alternative to chemical synthesis for producing antimicrobial peptides.